ratios (T2-T3/PP) of biomarkers were 1.3-1.6, except for GCDCA-S and kynurenine where the ratios were ~5. The net renal secretory clearance and net unbound secretory clearance ratios of pyridoxic acid, p-cresol sulfate, p-cresol glucuronide, 3-indoxyl sulfate, and GCDCA-S were similar to the values listed above. Overall, OAT1/3 activity (as measured by endogenous biomarkers) is increased in T2-T3, consistent with available in vivo OAT1/3 substrate drug data. The studied biomarkers can be utilized in the future to quantify pregnancy-related changes in OAT1/3 transport activities across all trimesters.
Thakur et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: